The global healthcare and pharmaceutical industry is frequently faced with having to find new ways of innovating and carrying out its work in order to overcome tragic circumstances that will typically come with a huge human cost.

During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal threat posed by the virus.

The pharmaceutical industry has evolved in many ways over the past 50 years, and one of the most notable is its globalisation. Today, innovative drug products are being developed around the world and are marketed and sold to a much larger proportion of the global population. The clinical trial industry is globalising alongside its big sister pharma, and both sectors are in need of global logistics partners that can serve their growing and constantly evolving demands. 

The life science industry has one clear, simple goal: to improve and in many cases save patients’ lives through innovative and effective drug therapies. For this to be realised, every company in the industry must strive towards excellence, right the way from the R&D laboratory to the factory floor, distribution warehouse, and beyond.

There are two specific aspects that are a bit different from the responsibilities of others. The first one is the “leadership” aspect of the CEO role. You need to guide your organization, defining a very clear mission and vision for your team, and make it live in the day-to-day. The second aspect is what I would call the “service mindset.” As a CEO, you are at the service of your employees, shareholders, customers and many others. You need to support and contribute to creating value every single day at your organization.

When a clinical trial organisation was looking to set up a new trial with the aim of servicing children and young adults who have a particular chronic condition, they turned to CRYOPDP to help. The syndrome is incurable, but early diagnosis and treatment can help prevent or reduce the number of challenges that individuals may experience and which may be more of a problem if diagnosis or treatment is delayed.

While moving cryogenically and deep-frozen-state stored biomaterials it is critical to not only provide the right equipment, but also ensure that chain-of-custody and visibility are a top priority. Managing a laboratory move correctly is more than just moving samples, it is about doing every step correctly and documenting it to ensure that proper protocols are followed.